» Articles » PMID: 20494598

Classification and Identification of Opioid Addiction in Chronic Pain Patients

Overview
Journal Eur J Pain
Publisher Wiley
Date 2010 May 25
PMID 20494598
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Addiction is a feared consequence of long-term opioid treatment of chronic pain patients. The ICD-10 and DSM-IV diagnostic addiction criteria may not be appropriate in these patients. Therefore Portenoy's criteria (PC) were launched. The aim was to estimate the prevalence of addiction, to investigate whether PC were applicable and to compare these criteria with the ICD-10 criteria. The study was cross-sectional and included 253 patients with chronic pain at a tertiary pain centre. Patients were screened for addiction by a physician and a nurse. The addiction prevalence was 14.4% according to ICD-10 and 19.3% according to PC. A significant difference between the prevalence of addiction according to ICD-10 and to PC was found. The inter-rater reliability was 0.95 for ICD-10 and 0.93 for PC. The sensitivity of PC was 0.85 and the specificity was 0.96. According to PC patients classified as addicted were treated with significantly higher opioid doses, drank more alcohol, smoked more tobacco, used benzodiazepines and had higher levels of depression. According to ICD-10 patients classified as addicted used higher doses of opioids, drank more alcohol and had higher scores of anxiety and depression. High opioid doses, concomitant use of alcohol and younger age were risk factors. The risk profile for PC was different to ICD-10 by adding risk factors as concomitant use of benzodiazepines, having depression and low educational level. PC seems to be appropriate for diagnosing addiction in opioid treated pain patients and seems to be more sensitive and specific than ICD-10 criteria.

Citing Articles

Trends in the prescription of opioids and gabapentinoids in patients with failed back surgery syndrome in Korea: a population-based study.

Oh J, Yeo J Korean J Pain. 2023; 37(1):73-83.

PMID: 38130090 PMC: 10764216. DOI: 10.3344/kjp.23246.


Opioid Agents and Cardiac Arrhythmia: A Literature Review.

Golibkhon A, Akbar Gafur Ugli B, Makhamadjonov Farkhod Ugli M Cureus. 2023; 15(4):e38007.

PMID: 37228540 PMC: 10207988. DOI: 10.7759/cureus.38007.


Positive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies.

Gallagher C, Ha D, Harvey R, Vandenberg R Pharmacol Rev. 2023; 74(4):933-961.

PMID: 36779343 PMC: 9553105. DOI: 10.1124/pharmrev.122.000583.


Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care.

Laporte C, Fortin F, Dupouy J, Quirin A, Pereira B, Chenaf C Int J Environ Res Public Health. 2022; 19(22).

PMID: 36429565 PMC: 9690529. DOI: 10.3390/ijerph192214845.


Two data-driven approaches to identifying the spectrum of problematic opioid use: A pilot study within a chronic pain cohort.

Schirle L, Jeffery A, Yaqoob A, Sanchez-Roige S, Samuels D Int J Med Inform. 2021; 156:104621.

PMID: 34673309 PMC: 8609775. DOI: 10.1016/j.ijmedinf.2021.104621.